Singapore, Oct. 10 -- The Health Sciences Authority received information related to the study titled 'A Long-Term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Arterial Hypertension'. The following are the other relevant details related to the trial:
Therapeutic Area: Cardiology
Trial Centre(s):
Tan Tock Seng Hospital
Trial Status: NA
Principal Investigator(s):
Dr Mok Kwang How
Published by HT Digital Content Services with permission from Health Daily Digest....